R
Roivant Sciences Ltd. (ROIV)
NMS – Real Time Price. Currency in USD
38.88
+2.26 (6.17%)
At close: Nov 06, 2026, 4:00 PM EST
38.88
0.00 (0.00%)
After-hours: Nov 06, 2026, 4:30 PM EST
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
38.88
+2.26 (6.17%)
At close: Nov 06, 2026, 4:00 PM EST
38.88
0.00 (0.00%)
After-hours: Nov 06, 2026, 4:30 PM EST
No Data
There are no news for this stock.
Cash and short-term investments ($3.8B) exceed total debt ($107.2M), giving strong financial flexibility
Current assets ($4.7B) comfortably exceed current liabilities ($283.6M), a current ratio of 16.72
Debt-to-equity ratio (0.02) is below the industry average (0.21), showing prudent use of debt
Operating profit (EBIT) is negative, so earnings do not cover interest costs
Negative free cash flow -$270.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 16.72 | 4.35 | 10 | |
| Quick ratio | 16.72 | 3.82 | 10 | |
| Debt to Equity | 0.03 | 0.21 | 9.0 | |
| Debt to Assets | 0.02 | 0.16 | 9.0 | |
| Interest coverage | N/A | -2.33 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 (Mar 2023) | 2023 (Mar 2024) | 2024 (Mar 2025) | 2025 (Mar 2026) | TTM |
|---|---|---|---|---|---|
| Total Revenue | 61M | 33M | 29M | 8M | 8M |
| Gross Profit | 29M | 21M | 21M | 4M | 3M |
| Operating Income | -1.08B | -825M | -1.11B | -1.27B | -1.37B |
| Net Income | -1.01B | 4.35B | -172M | -300M | -266M |
| EBITDA | -1.05B | -814M | -1.11B | -1.26B | -1.36B |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | 38.70 | 82.62 | 7.0 | |
| Operating margin % | -25408.11 | -6.79 | 1.0 | |
| Net margin % | -13164.84 | -19.13 | 1.0 | |
| EBITDA margin % | -25366.50 | -1.70 | 1.0 | |
| Cash flow margin % | -18758.95 | -6.16 | 1.0 | |
| Weighted average score | 2.2 | |||
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| ROA | -9.41 | -12.54 | 1.0 | |
| ROE | -11.14 | -16.30 | 1.0 | |
| ROIC | -10.94 | -15.82 | 1.0 | |
| ROCE | -26.71 | -15.91 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 163.86 | -81.57 | 5.5 |
| Next quarter | 619.46 | -113.98 | 5.5 |
| Current year | 593.33 | -153.84 | 5.5 |
| Next year | 644.85 | 5.26 | 7.5 |
| Weighted average score | 6.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -42.77 | -162.64 | -219.87 | -64.11 | 1.0 |
| Y/Y | -33.54 | 15.01 | -32.95 | -29.98 | 3.0 |
| 3y average | -43.11 | 117.59 | 108.21 | 3.5 | 6.3 |
| 5y average | 2.77 | 65.79 | 81.58 | -7.42 | 6.3 |
| Weighted average score | 4.2 | ||||
| NAME | RATIO | INDUSTRY | 5Q TREND | SCORE |
|---|---|---|---|---|
| P/E | N/A | 33.60 | 1.0 | |
| PEG (5yr expected) | N/A | 1.20 | 1.0 | |
| P/S | 3434.50 | 9.17 | 1.6 | |
| P/B | 6.13 | 4.32 | 3.6 | |
| Weighted average score | 1.8 | |||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | N/A | 0.98 | N/A |
| Payout ratio | N/A | 16.18 | N/A |
| 5-year dividend growth rate | N/A | 4.64 | N/A |
| Years of dividend increase | 0.00 | 2.00 | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Narrow | 2.0 |
| Intangible assets | Narrow | 4.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | Narrow | 3.0 |
| Weighted average score | 2.2 | |